Neonatology
Prenatal Development of Malformed Fetuses at 28–42 Weeks of Gestational Age (Anencephalus, Hydrocephalus, Down’s Syndrome, Cleft Lip and Palate, and Hypospadias)II. Length Gains Institute for the Care of Mother and Child, Prague
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: September 16, 2009
Issue release date: 1973
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Abstract
Mean body sizes of 416 anencephalus, 504 hydrocephalus, 550 Down’s syndrome cases, 653 cases of cleft lip and/or palate and of 1,047 hypospadias were calculated for each week of prenatal life between 28 and 42 weeks of pregnancy. Except for anencephalus no considerable differences were found in comparison with standard growth. A tendency to undergrowth is most pronounced in the phase of reduced growth of fetuses with Down’s syndrome and hypospadias. The reduced growth in anencephalus, hydrocephalus and in cases withcleft lip and/or palate is absent.
© 1973 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Published online: September 16, 2009
Issue release date: 1973
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission